Blantucas, Norijane .
HRN: 16-65-04 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/06/2025
CEFUROXIME 1.5GM (VIAL)
04/06/2025
04/12/2025
ORAL
500mg
Bid
Cs
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes